Cargando…
Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes
BACKGROUND: We report prospectively captured clinical toxicity and patient reported outcomes in a single institutional cohort of patients treated for prostate cancer with proton beam therapy (PBT). This is the largest reported series of patients treated mostly with pencil beam scanning PBT. METHODS:...
Autores principales: | Lee, Howard J., Macomber, Meghan W., Spraker, Matthew B., Bowen, Stephen R., Hippe, Daniel S., Fung, Angela, Russell, Kenneth J., Laramore, George E., Rengan, Ramesh, Liao, Jay, Apisarnthanarax, Smith, Zeng, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142310/ https://www.ncbi.nlm.nih.gov/pubmed/30223877 http://dx.doi.org/10.1186/s13014-018-1127-6 |
Ejemplares similares
-
Analysis of Gastrointestinal Toxicity in Patients Receiving Proton Beam Therapy for Prostate Cancer: A Single-Institution Experience
por: Lee, Howard J., et al.
Publicado: (2018) -
Proton Therapy for Malignant Pleural Mesothelioma: A Three Case Series Describing the Clinical and Dosimetric Advantages of Proton-Based Therapy
por: Lee, Howard, et al.
Publicado: (2017) -
Heart Dose and Outcomes in Radiation Treatment for Esophageal Cancer
por: Macomber, Meghan W, et al.
Publicado: (2018) -
Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective Registry
por: Jongen, Aurélien, et al.
Publicado: (2021) -
Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes
por: Zou, Zhenwei, et al.
Publicado: (2020)